Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | IDE161 |
Synonyms | |
Therapy Description |
IDE161 inhibits PARG, potentially decreasing tumor cell proliferation (Cancer Res 2023;83(7_Suppl):Abstract nr 6093). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
IDE161 | IDE 161|IDE-161 | IDE161 inhibits PARG, potentially decreasing tumor cell proliferation (Cancer Res 2023;83(7_Suppl):Abstract nr 6093). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05787587 | Phase I | IDE161 | A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors | Recruiting | USA | 0 |